Clinical Trial Update: Registry for Patients With Acquired Resistance to Small Molecule Kinase Inhibitors in Non-Small-Cell Lung Cancer

View source ↗

Summary

A completed clinical trial registry update tracking patients with acquired resistance to small molecule kinase inhibitors in unresectable or metastatic non-smal…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Snippet

Sponsor: Memorial Sloan Kettering Cancer Center | Conditions: Unresectable or Metastatic Non-small Cell Lung Cancer (NSCLC) | Status: COMPLETED